Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (281-290 of 505) with videos related to

Pageof 51
Sort By:
Respiratory Research|July 17, 2007
Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthmaCatherine M Houghton, Naomi Lawson, Zoe L Borrill, et al.
Lancet (London, England)|September 7, 2016
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trialDave Singh, Alberto Papi, Massimo Corradi, et al.
Cytokine|March 25, 2008
Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophagesLauren Kent, Lucy Smyth, Chris Clayton, et al.
Respiratory Research|June 30, 2019
Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary diseaseBrian R Leaker, Dave Singh, Grant C Nicholson, et al.
Lancet (London, England)|April 8, 2017
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trialJørgen Vestbo, Alberto Papi, Massimo Corradi, et al.
ERJ Open Research|December 10, 2025
Circadian variability in breath volatiles is affected by the timing of inhaled corticosteroids in asthmaRan Wang, Robert Maidstone, Waqar Ahmed, et al.
Plos One|May 25, 2013
Evaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionateJonathan Plumb, Laura Robinson, Simon Lea, et al.
The European Respiratory Journal|June 2, 2012
A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbationsDave Singh, Jorg Kampschulte, Jadwiga A Wedzicha, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 13, 2022
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOSMona Bafadhel, Klaus F Rabe, Fernando J Martinez, et al.
Respiratory Research|May 13, 2017
COPD monocytes demonstrate impaired migratory abilityArjun K Ravi, Jonathan Plumb, Rosemary Gaskell, et al.
Pageof 51

Showing results (281-290 of 505) with videos related to

Sort By:
Pageof 51
Respiratory Research|July 17, 2007
Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthmaCatherine M Houghton, Naomi Lawson, Zoe L Borrill, et al.
Lancet (London, England)|September 7, 2016
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trialDave Singh, Alberto Papi, Massimo Corradi, et al.
Cytokine|March 25, 2008
Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophagesLauren Kent, Lucy Smyth, Chris Clayton, et al.
Respiratory Research|June 30, 2019
Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary diseaseBrian R Leaker, Dave Singh, Grant C Nicholson, et al.
Lancet (London, England)|April 8, 2017
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trialJørgen Vestbo, Alberto Papi, Massimo Corradi, et al.
ERJ Open Research|December 10, 2025
Circadian variability in breath volatiles is affected by the timing of inhaled corticosteroids in asthmaRan Wang, Robert Maidstone, Waqar Ahmed, et al.
Plos One|May 25, 2013
Evaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionateJonathan Plumb, Laura Robinson, Simon Lea, et al.
The European Respiratory Journal|June 2, 2012
A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbationsDave Singh, Jorg Kampschulte, Jadwiga A Wedzicha, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 13, 2022
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOSMona Bafadhel, Klaus F Rabe, Fernando J Martinez, et al.
Respiratory Research|May 13, 2017
COPD monocytes demonstrate impaired migratory abilityArjun K Ravi, Jonathan Plumb, Rosemary Gaskell, et al.
Pageof 51